サマリー

市場分析とインサイト世界と米国のRegorafenib市場
当レポートでは、世界および米国のRegorafenib市場に焦点を当てています。
2020年のRegorafenibの世界市場規模はXX百万米ドルで、2021-2027年の間にXX％のCAGRで、2027年末までにXX百万米ドルに達すると予想されています。米国では、Regorafenibの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX％のCAGRで成長すると予測されています。

世界のRegorafenibの範囲と市場規模
Regorafenib市場は、地域（国）別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のRegorafenib市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年までの地域（国）別、タイプ別、アプリケーション別の収益と予測に焦点を当てています。
米国市場では、2016年から2027年までのRegorafenibの市場規模を、プレイヤー別、タイプ別、アプリケーション別に取り上げています。主要なプレイヤーには、米国で重要な役割を果たす世界的なプレイヤーや地域のプレイヤーが含まれます。

タイプ別セグメント
瓶詰め包装
フィルムコーティング包装

アプリケーション別セグメント
転移性大腸がん
進行性消化管間質性腫瘍（Gastrointestinal Stromal Tumours
進行性肝細胞癌
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
バイエル薬品
ビーコン・ファーマシューティカルズ
ドラッグ・インターナショナル

ページTOPに戻る

目次

1 Study Coverage
1.1 Regorafenib Product Introduction
1.2 Market by Type
1.2.1 Global Regorafenib Market Size Growth Rate by Type
1.2.2 Bottled Packaging
1.2.3 Film Coated Packaging
1.3 Market by Application
1.3.1 Global Regorafenib Market Size Growth Rate by Application
1.3.2 Metastatic Colorectal Cancer
1.3.3 Advanced Gastrointestinal Stromal Tumours
1.3.4 Advanced Hepatocellular Carcinoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Regorafenib Market Size, Estimates and Forecasts
2.1.1 Global Regorafenib Revenue 2016-2027
2.1.2 Global Regorafenib Sales 2016-2027
2.2 Global Regorafenib, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Regorafenib Historical Market Size by Region (2016-2021)
2.3.1 Global Regorafenib Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Regorafenib Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Regorafenib Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Regorafenib Sales Forecast by Region (2022-2027)
2.4.2 Global Regorafenib Revenue Forecast by Region (2022-2027)

3 Global Regorafenib Competitor Landscape by Players
3.1 Global Top Regorafenib Manufacturers by Sales
3.1.1 Global Regorafenib Sales by Manufacturer (2016-2021)
3.1.2 Global Regorafenib Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Regorafenib Manufacturers by Revenue
3.2.1 Key Regorafenib Manufacturers Covered: Ranking by Revenue
3.2.2 Global Regorafenib Revenue by Manufacturers (2016-2021)
3.2.3 Global Regorafenib Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Regorafenib Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Regorafenib Revenue in 2020
3.2.6 Global Regorafenib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Regorafenib Price by Manufacturers
3.4 Global Regorafenib Manufacturing Base Distribution, Product Types
3.4.1 Regorafenib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Regorafenib Product Type
3.4.3 Date of International Manufacturers Enter into Regorafenib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Regorafenib Market Size by Type (2016-2021)
4.1.1 Global Regorafenib Sales by Type (2016-2021)
4.1.2 Global Regorafenib Revenue by Type (2016-2021)
4.1.3 Regorafenib Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Regorafenib Market Size Forecast by Type (2022-2027)
4.2.1 Global Regorafenib Sales Forecast by Type (2022-2027)
4.2.2 Global Regorafenib Revenue Forecast by Type (2022-2027)
4.2.3 Regorafenib Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Regorafenib Market Size by Application (2016-2021)
5.1.1 Global Regorafenib Sales by Application (2016-2021)
5.1.2 Global Regorafenib Revenue by Application (2016-2021)
5.1.3 Regorafenib Price by Application (2016-2021)
5.2 Regorafenib Market Size Forecast by Application (2022-2027)
5.2.1 Global Regorafenib Sales Forecast by Application (2022-2027)
5.2.2 Global Regorafenib Revenue Forecast by Application (2022-2027)
5.2.3 Global Regorafenib Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Regorafenib Market Size YoY Growth 2016-2027
6.1.1 United States Regorafenib Sales YoY Growth 2016-2027
6.1.2 United States Regorafenib Revenue YoY Growth 2016-2027
6.1.3 United States Regorafenib Market Share in Global Market 2016-2027
6.2 United States Regorafenib Market Size by Players (International and Local Players)
6.2.1 United States Top Regorafenib Players by Sales (2016-2021)
6.2.2 United States Top Regorafenib Players by Revenue (2016-2021)
6.3 United States Regorafenib Historic Market Review by Type (2016-2021)
6.3.1 United States Regorafenib Sales Market Share by Type (2016-2021)
6.3.2 United States Regorafenib Revenue Market Share by Type (2016-2021)
6.3.3 United States Regorafenib Price by Type (2016-2021)
6.4 United States Regorafenib Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Regorafenib Sales Forecast by Type (2022-2027)
6.4.2 United States Regorafenib Revenue Forecast by Type (2022-2027)
6.4.3 United States Regorafenib Price Forecast by Type (2022-2027)
6.5 United States Regorafenib Historic Market Review by Application (2016-2021)
6.5.1 United States Regorafenib Sales Market Share by Application (2016-2021)
6.5.2 United States Regorafenib Revenue Market Share by Application (2016-2021)
6.5.3 United States Regorafenib Price by Application (2016-2021)
6.6 United States Regorafenib Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Regorafenib Sales Forecast by Application (2022-2027)
6.6.2 United States Regorafenib Revenue Forecast by Application (2022-2027)
6.6.3 United States Regorafenib Price Forecast by Application (2022-2027)

7 North America
7.1 North America Regorafenib Market Size YoY Growth 2016-2027
7.2 North America Regorafenib Market Facts & Figures by Country
7.2.1 North America Regorafenib Sales by Country (2016-2021)
7.2.2 North America Regorafenib Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Regorafenib Market Size YoY Growth 2016-2027
8.2 Asia Pacific Regorafenib Market Facts & Figures by Region
8.2.1 Asia Pacific Regorafenib Sales by Region (2016-2021)
8.2.2 Asia Pacific Regorafenib Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Regorafenib Market Size YoY Growth 2016-2027
9.2 Europe Regorafenib Market Facts & Figures by Country
9.2.1 Europe Regorafenib Sales by Country (2016-2021)
9.2.2 Europe Regorafenib Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Regorafenib Market Size YoY Growth 2016-2027
10.2 Latin America Regorafenib Market Facts & Figures by Country
10.2.1 Latin America Regorafenib Sales by Country (2016-2021)
10.2.2 Latin America Regorafenib Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Regorafenib Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Regorafenib Market Facts & Figures by Country
11.2.1 Middle East and Africa Regorafenib Sales by Country (2016-2021)
11.2.2 Middle East and Africa Regorafenib Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Bayer Pharmaceuticals
12.1.1 Bayer Pharmaceuticals Corporation Information
12.1.2 Bayer Pharmaceuticals Description and Business Overview
12.1.3 Bayer Pharmaceuticals Regorafenib Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer Pharmaceuticals Regorafenib Products Offered
12.1.5 Bayer Pharmaceuticals Recent Development
12.2 Beacon Pharmaceuticals
12.2.1 Beacon Pharmaceuticals Corporation Information
12.2.2 Beacon Pharmaceuticals Description and Business Overview
12.2.3 Beacon Pharmaceuticals Regorafenib Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Beacon Pharmaceuticals Regorafenib Products Offered
12.2.5 Beacon Pharmaceuticals Recent Development
12.3 Drug International
12.3.1 Drug International Corporation Information
12.3.2 Drug International Description and Business Overview
12.3.3 Drug International Regorafenib Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Drug International Regorafenib Products Offered
12.3.5 Drug International Recent Development
12.11 Bayer Pharmaceuticals
12.11.1 Bayer Pharmaceuticals Corporation Information
12.11.2 Bayer Pharmaceuticals Description and Business Overview
12.11.3 Bayer Pharmaceuticals Regorafenib Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bayer Pharmaceuticals Regorafenib Products Offered
12.11.5 Bayer Pharmaceuticals Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Regorafenib Industry Trends
13.2 Regorafenib Market Drivers
13.3 Regorafenib Market Challenges
13.4 Regorafenib Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Regorafenib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer